|
# | Authors | Title | Main findings |
|
17 | Zhang et al. | TCL-036: Alternations in the Skin Microbiota Are Associated with Symptom Severity in Mycosis Fungoides | Skin microbiota alterations are linked to symptom severity in mycosis fungoides |
16 | Dehner et al. | Skin Microbiota as Antigenic Triggers for Cutaneous T Cell Lymphoma | Skin microbiota may act as antigenic triggers for CTCL |
14 | Salava et al. | Skin Microbiome in Cutaneous T-Cell Lymphoma by 16S and Whole-Genome Shotgun Sequencing | Investigated skin microbiome in CTCL using 16S and whole-genome shotgun sequencing |
15 | Harkins et al. | Cutaneous T-Cell Lymphoma Skin Microbiome Characterized by Shifts in Certain Commensal Bacteria | CTCL skin microbiome shows shifts in certain commensal bacteria compared to healthy controls |
10 | Lewis | Cutaneous microbiota in the pathogenesis of cutaneous T-cell lymphoma and role of antibiotic therapy | Explores the role of cutaneous microbiota and antibiotic therapy in CTCL pathogenesis |
19 | Hooper et al. | Skin microbiome in cutaneous T-cell lymphoma associated with phototherapy treatment response | Skin microbiome in CTCL is linked to phototherapy treatment response |
25 | Wu & Hwang | A Microbiota-Dependent, STAT3-Driven Mouse Model of Cutaneous T-Cell Lymphoma | Describes a microbiota-dependent, STAT3-driven mouse model of CTCL |
37 | Fanok et al. | Analysis of molecular etiology and bacterial triggers of cutaneous T-cell lymphoma | Investigates molecular etiology and bacterial triggers of CTCL |
6 | Kadin et al. | Evidence linking atopy and staphylococcal superantigens to lymphomatoid papulosis pathogenesis | Links atopy and staphylococcal superantigens to lymphomatoid papulosis pathogenesis |
9 | Hooper et al. | Gut dysbiosis in CTCL characterized by shifts in bacterial taxa and decreased diversity | Gut dysbiosis in CTCL shows shifts in bacterial taxa and decreased diversity in advanced disease |
7 | Emge et al. | MRSA is an important pathogen in erythrodermic CTCL patients | MRSA plays a significant role in erythrodermic CTCL patients |
8 | Fujii | Pathogenesis of cutaneous T-cell lymphoma: Involvement of Staphylococcus aureus | Staphylococcus aureus involvement in CTCL pathogenesis |
20 | Fanok et al. | Role of Dysregulated Cytokine Signaling and Bacterial Triggers in CTCL Pathogenesis | Dysregulated cytokine signaling and bacterial triggers play a role in CTCL pathogenesis |
21 | Krejsgaard et al. | Staphylococcal enterotoxins stimulate lymphoma-associated immune dysregulation | Staphylococcal enterotoxins contribute to lymphoma-associated immune dysregulation |
22 | Blümel et al. | Staphylococcus aureusalpha-toxin inhibits CD8 (+) T-cell-mediated killing of cancer cells in CTCL | S. aureusalpha-toxin hinders CD8 (+) T-cell-mediated killing of cancer cells in CTCL |
27 | Lindahl et al. | Staphylococcus aureus and Antibiotics in Cutaneous T-Cell Lymphoma | S. aureus and antibiotics’ role in CTCL |
23 | Willerslev-Olsen et al. | Staphylococcus aureus enterotoxins induce FOXP3 in neoplastic T-cells in Sézary syndrome | S. aureus enterotoxins induce FOXP3 expression in neoplastic T-cells in Sézary syndrome |
24 | Willerslev-Olsen et al. | Staphylococcus aureus Induces STAT5-Dependent miR-155 Expression in Cutaneous T-Cell Lymphoma | S. aureus induces STAT5-dependent miR-155 expression in CTCL |
11 | Lewis et al. | The “Duvic Regimen” for Erythrodermic Flares Secondary to Staphylococcus aureus in Mycosis Fungoides | Describes the “Duvic Regimen” for treating erythrodermic flares caused by S. aureus in mycosis fungoides |
26 | Willerslev-Olsen et al. | Staphylococcal enterotoxin A (SEA) stimulates STAT3 activation and IL-17 expression in CTCL | SEA activates STAT3 and induces IL-17 expression in CTCL |
12 | Lindahl et al. | Antibiotics inhibit tumor activity and disease in cutaneous T-cell lymphoma | Antibiotics inhibit tumor activity and disease progression in CTCL |
|